Passage Bio PASG

$ 0.66 0.92%

Quarterly report 2024-Q3
added 11-13-2024

Passage Bio Balance Sheet 2011-2024 | PASG

Annual Balance Sheet Passage Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	4.58 M	-7.49 M	-	-135 M	-159 M	-24.9 M	-	-	-	-	-	-	-
Long Term Debt	22.9 M	23.8 M	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	3.37 M	3.28 M	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	2.12 M	580 K	45.3 M	-	-	-	-	-	-	-
Total Current Liabilities	16.3 M	18.4 M	29.5 M	21.2 M	-	-	-	-	-	-	-	-	-
Total Liabilities	39.3 M	42.2 M	36.4 M	23.3 M	4.26 M	45.6 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-594 M	-492 M	-356 M	-171 M	-58.7 M	-13 M	-	-	-	-	-	-	-
Total Assets	151 M	244 M	355 M	328 M	179 M	33.5 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	21.7 M	34.6 M	129 M	135 M	159 M	-	-	-	-	-	-	-	-
Book Value	111 M	201 M	319 M	305 M	174 M	-12.2 M	-	-	-	-	-	-	-
Total Shareholders Equity	111 M	201 M	319 M	305 M	-56.3 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Passage Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	22.1 M	22.4 M	22.8 M	22.9 M	23.2 M	23.4 M	23.6 M	23.8 M	24 M	-	24.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	39 M	34.8 M	35.6 M	39.3 M	43 M	43.3 M	42.9 M	42.2 M	45.7 M	-	51.9 M	36.4 M	28.7 M	37.3 M	23.7 M	23.3 M	23.3 M	23.3 M	23.3 M	4.26 M	4.26 M	4.26 M	4.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-647 M	-627 M	-611 M	-594 M	-578 M	-551 M	-527 M	-492 M	-465 M	-	-399 M	-356 M	-305 M	-258 M	-210 M	-171 M	-171 M	-171 M	-171 M	-58.7 M	-58.7 M	-58.7 M	-58.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	112 M	125 M	141 M	151 M	169 M	194 M	213 M	244 M	270 M	-	333 M	355 M	391 M	440 M	465 M	328 M	328 M	328 M	328 M	179 M	179 M	179 M	179 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	32.3 M	24.8 M	36.8 M	21.7 M	33.6 M	30.3 M	33.4 M	34.6 M	62.6 M	91.1 M	102 M	129 M	163 M	215 M	250 M	135 M	135 M	135 M	135 M	159 M	159 M	159 M	159 M	24.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	72.7 M	90.6 M	105 M	111 M	126 M	150 M	170 M	201 M	224 M	-	281 M	319 M	362 M	402 M	442 M	305 M	305 M	305 M	305 M	174 M	174 M	174 M	174 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	72.7 M	90.6 M	105 M	111 M	126 M	150 M	170 M	201 M	224 M	248 M	281 M	319 M	362 M	402 M	442 M	305 M	305 M	305 M	305 M	-56.3 M	-56.3 M	-56.3 M	-56.3 M	-12.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency